DEA Seeks Feedback on Updated Controlled Substances Form
Published Date: 1/2/2026
Notice
Summary
The DEA is updating a form used by people and companies who handle controlled substances, like medicines that need special permission. They want your feedback on how to make the form easier and less time-consuming. Comments are open for 60 days until March 3, 2026, and this update won’t cost extra money but aims to simplify the process.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Businesses can register to view DEA CSA data
If you are a business that is not a DEA registrant, you can apply to register for access to the Controlled Substances Act (CSA) Database System to see the names and registration statuses of all DEA-registrants. The application must be completed and applicants are required to re-apply annually using the DEA form.
$20 annual fee per applicant
DEA will charge a $20 fee to each applicant for the Registration for CSA Data-Use Request to recover processing costs. DEA estimates 16,000 respondents, which produces an annual monetized cost of $320,000 due to the $20 fee charged to each respondent.
Time burden: 15 minutes per application
DEA estimates each Registration for CSA Data-Use Request takes 15 minutes (0.25 hours) to complete. DEA estimates 16,000 total responses and a total annual burden of 4,000 hours for all respondents.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06329 — Notice of Lodging of Proposed Material Modification of Consent Decree Under the Clean Water Act
The City of Columbia, South Carolina, must finish four new sewer projects by January 1, 2029, to fix its sewer system and delay a related cleanup program until those projects are done. This change updates a 2014 agreement to stop sewer overflows and protect local water. People have 30 days from April 2, 2026, to share their thoughts on this plan.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-06118 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement, With Change, of a Previously Approved Collection for Which Approval Has Expired: Census of Prosecutor Offices
The Department of Justice is bringing back the Census of Prosecutor Offices with some updates to make it easier and faster to fill out. This survey affects prosecutor offices across the country and helps gather important info to improve justice stats. Comments on the changes are open until May 29, 2026, and the new process aims to save time and reduce hassle.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
Previous / Next Documents
Previous: 2025-24219 — Notice of OFAC Sanctions Action
The U.S. Treasury’s OFAC just blocked the property of two Iranian individuals linked to a company involved in weapons of mass destruction. This means Americans can’t do business with them, and any assets they have under U.S. control are frozen starting December 30, 2025. It’s a clear move to stop dangerous activities and protect U.S. interests.
Next: 2025-24221 — Notice of Public Hearing
The U.S. International Development Finance Corporation is hosting a virtual public hearing on January 21, 2026, to hear ideas and feedback from anyone interested. If you want to speak or send a written statement, you need to sign up by January 14. This is a great chance for organizations and individuals to influence important development finance decisions without any cost to join!
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in